|
Lincoln Pharmaceuticals Ltd
intends to set up a USFDA plant
for oral formulations in Ahmedabad
at a cost of around Rs 50
crore. The company plans to
strengthen its international
business through the USFDA
plant for regulatory markets
like USA, the UK, Europe, Brazil
and South Africa. With this, the
company can target sustainable
growth through strong regulatory
and R&D strategies.
|